Showing 1 - 20 results of 49 for search 'Tallman, MS', query time: 0.41s
Refine Results
-
1
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) U... by Moorman, A, Harrison, C, Richards, S, Fielding, A, Tallman, MS, Litzow, MR, Rowe, J, Goldstone, A, Dewald, G
Published 2005Conference item -
2
-
3
-
4
-
5
Does imatinib change the outcome in philapdelphia chromosome positive acute lympooblastic leukaemia in adults? Data from the UKALLXII/ECOG2993 study by Fielding, A, Richards, S, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Rowe, J, Tallman, MS, Goldstone, A
Published 2007Conference item -
6
Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph plus) acute lymphoblastic leukaemia (ALL). Results from... by Goldstone, A, Prentice, H, Durrant, J, Franklin, I, Harrison, G, Richards, S, Lazarus, H, Wiernik, P, Tallman, MS, Rowe, J
Published 2001Journal article -
7
Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remissi... by Rowe, J, Richards, S, Burnett, A, Wiernik, P, Harrison, G, Lazarus, H, Franklin, I, Prentice, G, Durrant, J, Tallman, MS, Goldstone, A
Published 2001Journal article -
8
Outcome in Philadelphia Chromosome Positive (Ph plus ) Adult ALL Patients (Pts) May Be More Determined by CD25 Expression Than by Ph Status Per Se by Paietta, E, Li, X, Richards, S, Racevskis, J, Dewald, G, Rowe, J, Tallman, MS, Lazarus, H, Litzow, MR, Goldstone, A, Wiernik, P
Published 2008Conference item -
9
Implications for the Use of Monoclonal Antibodies in Future Adult ALL Trials: Analysis of Antigen Expression in 505 B-Lineage (B-Lin) ALL Patients (pts) on the MRC UKALLXII/ECOG299... by Paietta, E, Li, X, Richards, S, Racevskis, J, Dewald, G, Rowe, J, Tallman, MS, Lazarus, H, Litzow, M, Goldstone, A, Wiernik, P
Published 2008Conference item -
10
-
11
Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993). by Goldstone, A, Richards, S, Wiernik, P, Franklin, I, Burnett, A, Lazarus, H, Prentice, H, Neuberg, D, Tallman, MS, Harrison, G, Rowe, J
Published 1999Journal article -
12
The outcome of 267 Philadelphia positive adults in the international UKALL12/ECOG E 2993 study. Final analysis and the role of allogeneic transplant in those under 50 years. by Goldstone, A, Chopra, R, Buck, G, Richards, M, Franklin, J, Lazarus, H, Wiemik, P, Tallman, MS, Prentice, H, Durrant, J, Rowe, J
Published 2003Conference item -
13
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A
Published 2010Conference item -
14
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A
Published 2010Conference item -
15
Adult patients with acute lymphoblastic leukemia (ALL) and central nervous system (CNS) leukemia at diagnosis may attain durable complete remissions (CR). Results from the internat... by Lazarus, H, Richards, S, Chopra, R, Litzow, MR, Burnett, A, Wiernik, P, Franklin, I, Tallman, MS, Buck, G, Durrant, J, Rowe, J, Goldstone, A
Published 2004Conference item -
16
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A
Published 2010Conference item -
17
Induction therapy for adults with acute lymphoblastic leukemia (ALL): Results of nearly 1,400 patients from the international ALL trial (MRC UKALL XII/ECOG E2993). by Rowe, J, Buck, G, Burnett, A, Chopra, R, Wiernik, P, Richards, S, Lazarus, H, Franklin, I, Litzow, MR, Prentice, H, Durrant, J, Tallman, MS, Goldstone, A
Published 2003Conference item -
18
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A
Published 2012Journal article -
19
Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial by Fielding, A, Buck, G, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Tallman, MS, Rowe, J, Goldstone, A
Published 2010Conference item -
20
Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial by Fielding, A, Buck, G, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Tallman, MS, Rowe, J, Goldstone, A
Published 2010Conference item